Skip to content

Clinical trials

Phase 2 Pyoderma Gangrenosum trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pyoderma Gangrenosum Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20131
20141
20171
20191
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Withdrawn2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oregon Health and Science University4
Icahn School of Medicine at Mount Sinai1
InflaRx GmbH1
Janssen Research & Development, LLC1
Ohio State University1
Wake Forest University Health Sciences1
Wright State University1
XOMA (US) LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pyoderma Gangrenosum11
Pyoderma3
Skin Diseases2
Skin Ulcer2
Wounds and Injuries2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.